Phase 4 Atrial Fibrillation Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• People who are scheduled for a planned (non-emergency) heart bypass surgery that uses a heart-lung bypass machine.
• People who are willing to sign a consent form agreeing to take part in the study.

Who may not be able to join:

• People whose heart's main pumping chamber is significantly weakened (pumping less than 35% of its normal capacity).
• People who have heart valve disease that also needs to be surgically corrected.
• People who have liver failure, including those with certain elevated liver enzyme levels (1.5 times or more above the normal range).
• People who have significant kidney disease where the kidneys are not filtering blood well enough (confirm with trial site for exact measurement details).
• People who have a heart rhythm condition called atrial fibrillation, whether it is constant, long-lasting, or comes and goes.
• People who already have a pacemaker implanted.
• People who have a known allergic reaction or sensitivity to the medication colchicine.
• People who have a low white blood cell count (a condition called neutropenia).
• People with a history of alcohol dependency or alcoholism.
• People who are not willing to sign the consent form to participate.

Important: Always verify eligibility with the trial site directly before applying.